login
register
Home
Getting Started
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
Conatus Pharmaceutic (CNAT) Stock Analyst Ratings
NASDAQ:CNAT - Nasdaq -
0.556
+0 (+0.18%)
After market: 0.54
-0.02 (-2.88%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
Buy % Consensus
0
CNAT
is currently not analyzed by any analysts.
Related screens
Find peers with buy consensus above 85%
CNAT Historical Analyst Ratings
CNAT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.
Historical Monthly Analyst Rating
-17
-15
-13
-11
-9
-7
-5
-3
-1
1
2
3
4
Related screens
Find peers 30% below price target
CNAT Current Analyst Rating
CNAT Current Analyst Buy, Sell and Hold Ratings.
Current Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Please enable JavaScript to continue using this application.
